Tag: Business

news-21112024-122547

Kura Oncology Licenses Leukemia Drug to Japanese Drugmaker

Kura Oncology and the Japanese drugmaker Kyowa Kirin have joined forces in a global partnership to work on Kura’s new treatment for acute leukemia. The drug, ziftomenib, is currently in a late-stage clinical trial...
news-20112024-122223

Apellis Triumphs while Astellas Faces Defeat

Good morning! Today, there is a lot of news from the American Heart Association's annual meeting, and former National Cancer Institute chief Ned Sharpless has launched a new biotech company called Jupiter. Here's what you...
news-20112024-062138

RFK Jr. Considered for Health Secretary as Pharma Execs Seek Stability

Robert F. Kennedy Jr., a well-known critic of the pharmaceutical industry, has been considered for the position of Health Secretary. He has been vocal about his views on how the industry has influenced U.S....
news-19112024-182028

Merck Drug Trial and Wegovy in China: Pharmalittle News Update

Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...
news-17112024-181301

Navigating the Corporate Ladder: Recent Movements and Trends

In the world of corporate movements and trends, it's always exciting to hear about new hires, promotions, and other changes within companies. If you have any news to share about someone new joining your...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
news-12112024-102000

Pharmalittle: GSK Leaves BIO, AbbVie Schizophrenia Drug Fails & More – Pharma News Update

Good morning, everyone, and welcome to a new week of work. We hope you had a restful weekend and are ready to dive back into the routine of online meetings and deadlines. Let's start...
news-12112024-041658

Ending 23andMe’s Drug Discovery Dream: What Went Wrong?

23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
news-10112024-214800

GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group

Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
news-07112024-155051

Biotech Outlook Post-Trump Presidency: What’s Next?

Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...
news-06112024-052955

Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees

Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
news-05112024-232810

Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation

Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...